Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Schweinfurt – page 2

23 clinical trials in Schweinfurt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Schweinfurt at a glance
23
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

23 trials in Schweinfurt

Open in trial search

Gastric cancer+1

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Adenocarcinoma gastric+3

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astellas Pharma Global Development Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Gout

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Universitaetsmedizin Greifswald KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Alliance Foundation Trials LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Schweinfurt

What the registry says about research in the country

01 Oncology: Breast Cancer Research

Multiple innovative trials focusing on breast cancer treatment, particularly examining new therapeutic combinations for different subtypes including HR-positive, HER2-positive, and triple-negative breast cancer.

  • Early-stage breast cancer interventions
  • Neoadjuvant therapy approaches
  • Targeted combination treatments

Studies are evaluating novel drug combinations with established treatments to improve patient outcomes.

02 Gastrointestinal Oncology

Comprehensive research into colorectal cancer and gastroesophageal cancers, with trials exploring both metastatic and non-metastatic disease states.

  • Advanced colorectal cancer treatments
  • Preoperative therapy strategies
  • Targeted immunotherapy approaches

Innovative combinations of immunotherapy and targeted agents are being tested to improve survival rates.

03 Gynecologic Oncology

Groundbreaking research in ovarian cancer treatment, focusing on newly diagnosed advanced cases and maintenance therapy strategies.

  • Advanced ovarian cancer protocols
  • Combination therapy approaches
  • Maintenance treatment strategies

Studies incorporate novel therapeutic combinations with standard treatments to enhance treatment efficacy.

04 Thoracic Oncology

Leading-edge research in non-small cell lung cancer, exploring innovative first-line treatments and targeted therapies.

  • Metastatic lung cancer treatments
  • Targeted molecular therapies
  • Immunotherapy combinations

Focus on personalized treatment approaches based on specific genetic markers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.